Skip to main content
Clinical Trials/NCT05149456
NCT05149456
Unknown
Not Applicable

Study of the Prevalence of Peripheral Artery Occlusive Disease (PAOD) in Women Hospitalized for Type 1 Myocardial Infarction in Intensive Cardiology Care

University Hospital, Strasbourg, France1 site in 1 country50 target enrollmentAugust 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PAOD - Peripheral Arterial Occlusive Disease
Sponsor
University Hospital, Strasbourg, France
Enrollment
50
Locations
1
Primary Endpoint
Study of the prevalence of peripheral artery occlusive disease (PAOD)
Last Updated
4 years ago

Overview

Brief Summary

The cardiovascular risk of women has been the subject of particular interest in recent years, in the world, in particular under the impetus of Cardiology companies, with more and more work focusing on the specificities of these diseases in women as well as differences in terms of management and prognosis with a literature mainly based on American data and which focuses particularly on ischemic heart disease.

The expected results are to have a prevalence of PAOD in an Alsatian cohort, most of the data we currently have from American data, with analysis of the impact of specific and non-specific risk factors in this cohort and their weight in PAOD.

Registry
clinicaltrials.gov
Start Date
August 15, 2021
End Date
August 31, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Study of the prevalence of peripheral artery occlusive disease (PAOD)

Time Frame: Files analysed retrospectively from January 01, 2021 to Jun 30, 2021 will be examined]

Study Sites (1)

Loading locations...

Similar Trials